Ligand · LHD

LHD · 2-[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]ethyl-[[4-azanyl-1-(methoxymethyl)-2-oxidanylidene-pyrimidin-5-yl]methyl]azanium

LHD, 2-[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]ethyl-[[4-azanyl-1-(methoxymethyl)-2-oxidanylidene-pyrimidin-5-yl]methyl]azanium (C18 H26 N9 O5 +1, 448.5 g/mol), in the MolNFT structures on GenesisL1…

Component: LHD
Formula: C18 H26 N9 O5 +1
Class: ligand
Structures: 1
PDB entries: 1

Binding sites

LHD in 1 structure; the first of them:

5TBJ · Crystal structure of mouse CARM1 in complex with inhibitor LH1452 · LHD A501 · binds TYR150, PHE151, TYR154, GLN159, MET163, GLY193, GLU215, ALA216 and 12 more

Residues it binds most

GLU 4, MET 4, TYR 4, GLY 4, PHE 4, SER 4, ALA 4, GLN 4, LYS 4, TRP 4 (residue and the binding sites it lines).

Found with

DXE · 1,2-dimethoxyethane
EDO · 1,2-ethanediol
PEG · Di(hydroxyethyl)ether
PG6 · 1-(2-methoxy-ethoxy)-2-{2-[2-(2-methoxy-ethoxy]-ethoxy}-ethane

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.